Dr. Goldberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St
Fmp130
New Haven, CT 06520Phone+1 203-785-7564Fax+1 203-785-3788
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2009 - 2012
Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
Icahn School of Medicine at Mount SinaiClass of 2006
Certifications & Licensure
CT State Medical License 2012 - 2025
MA State Medical License 2008 - 2013- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- MK-3475 in Melanoma and NSCLC Patients With Brain Metastases Start of enrollment: 2014 Mar 01
- S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer Start of enrollment: 2015 May 07
- Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC Start of enrollment: 2022 Feb 10
Publications & Presentations
PubMed
- 1 citationsCentral nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape.Michael Weller, Jordi Remon, Stefan Rieken, Philipp Vollmuth, Myung-Ju Ahn
Cancer Treatment Reviews. 2024-11-01 - 2 citationsTyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases FromandOncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).Luke R G Pike, Emily Miao, Lillian A Boe, Tejas Patil, Brandon S Imber
Journal of Clinical Oncology. 2024-10-20 - 1 citationsTreatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on Osimertinib.Nathaniel D Robinson, Maureen E Canavan, Peter L Zhan, Brooks V Udelsman, Ranjan Pathak
Clinical Lung Cancer. 2024-09-23
Journal Articles
- Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung CancerGuoping Cai, Sarah B Goldberg, Scott Gettinger, Anne Chiang, Roy S Herbst, David L Rimm, Kurt Schalper, Richard Lifton, Clinical Cancer Research
Press Mentions
Experts in TrainingJanuary 20th, 2021- Better Treatments for Lung Cancer That Spreads to the BrainNovember 18th, 2020
Dr. Goldberg Discusses the Diagnosis of Mesothelioma (Short Video)April 5th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
